Based on our assessment of the disease process prior to HCT, we believe that excessive inflammatory disease (a C-reactive protein > 100 mg/L in the month prior to conditioning) represents an unacceptable risk for an adverse outcome related to the HCT, but not necessarily in relation to the fungal infection with the possible exception of CNS disease. The gene discussed is CRP; the disease is fungal infectious disease.